These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2670206)

  • 1. Liposomes as carriers of antitumor agents: toward a clinical reality.
    Perez-Soler R
    Cancer Treat Rev; 1989 Jun; 16(2):67-82. PubMed ID: 2670206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipophilic cisplatin analogues entrapped in liposomes: role of intraliposomal drug activation in biological activity.
    Perez-Soler R; Khokhar AR
    Cancer Res; 1992 Nov; 52(22):6341-7. PubMed ID: 1423280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipophilic platinum complexes entrapped in liposomes: improved stability and preserved antitumor activity with complexes containing linear alkyl carboxylato leaving groups.
    Perez-Soler R; Han I; al-Baker S; Khokhar AR
    Cancer Chemother Pharmacol; 1994; 33(5):378-84. PubMed ID: 8306411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo antitumor activity of cis-bis-neodecanoato-trans-R,R-1, 2-diaminocyclohexane platinum(II) formulated in long-circulating liposomes.
    Mori A; Wu SP; Han I; Khokhar AR; Perez-Soler R; Huang L
    Cancer Chemother Pharmacol; 1996; 37(5):435-44. PubMed ID: 8599866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity and efficacy studies on a series of lipid-soluble dineodecanoato(trans-R,R- and trans-S,S-1,2-diaminocyclohexane) platinum (II) complexes entrapped in liposomes.
    Khokhar AR; al-Baker S; Perez-Soler R
    Anticancer Drugs; 1992 Apr; 3(2):95-100. PubMed ID: 1525398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical and biological studies on a series of lipid-soluble (trans-(R,R)- and -(S,S)-1,2-diaminocyclohexane)platinum(II) complexes incorporated in liposomes.
    Khokhar AR; al-Baker S; Brown T; Perez-Soler R
    J Med Chem; 1991 Jan; 34(1):325-9. PubMed ID: 1992134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of liposomes containing a lipophilic cisplatin derivative for clinical use.
    Perez-Soler R; Francis K; al-Baker S; Pilkiewicz F; Khokhar AR
    J Microencapsul; 1994; 11(1):41-54. PubMed ID: 8138874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes as carriers of different new lipophilic antitumour drugs: a preliminary report.
    Sampedro F; Partika J; Santalo P; Molins-Pujol AM; Bonal J; Perez-Soler R
    J Microencapsul; 1994; 11(3):309-18. PubMed ID: 8064554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ distribution and tumor uptake of liposome entrapped cis-bis-neodecanoato trans-R, R-1,2 diaminocyclohexane platinum (II) administered intravenously and into the proper hepatic artery.
    Khokhar AR; Wright K; Siddik ZH; Perez-Soler R
    Cancer Chemother Pharmacol; 1988; 22(3):223-7. PubMed ID: 3409456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II).
    Perez-Soler R; Lopez-Berestein G; Lautersztain J; al-Baker S; Francis K; Macias-Kiger D; Raber MN; Khokhar AR
    Cancer Res; 1990 Jul; 50(14):4254-9. PubMed ID: 2364384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
    Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulation, controlled release, and antitumor efficacy of cisplatin delivered in liposomes composed of sterol-modified phospholipids.
    Kieler-Ferguson HM; Chan D; Sockolosky J; Finney L; Maxey E; Vogt S; Szoka FC
    Eur J Pharm Sci; 2017 May; 103():85-93. PubMed ID: 28263913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraliposomal conversion of lipophilic cis-bis-carboxylato-trans-R,R-1,2-diaminocyclohexane-platinum (II) complexes into cis-bis-dichloro-trans-R,R-1,2-diaminocyclohexane-platinum (II).
    Han I; Khokhar AR; Perez-Soler R
    Cancer Chemother Pharmacol; 1996; 39(1-2):17-24. PubMed ID: 8995495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cytotoxicity and reversal of resistance to cis-diamminedichloro-platinum(II) with entrapment of cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in multilamellar lipid vesicles.
    Perez-Soler R; Yang LY; Drewinko B; Lauterzstain J; Khokhar AR
    Cancer Res; 1988 Aug; 48(16):4509-12. PubMed ID: 3396003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal formulation and antitumor activity of 14-O-palmitoyl-hydroxyrubicin.
    Perez-Soler R; Priebe W
    Cancer Chemother Pharmacol; 1992; 30(4):267-71. PubMed ID: 1643693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraliposomal chemical activation patterns of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II) (L-NDDP)-a potential antitumour agent.
    Maclean DS; Khokhar AR; Tyle P; Perez-Soler R
    J Microencapsul; 2000; 17(3):307-22. PubMed ID: 10819419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antivascular and antitumor activities of liposome-associated drugs.
    Straubinger RM; Arnold RD; Zhou R; Mazurchuk R; Slack JE
    Anticancer Res; 2004; 24(2A):397-404. PubMed ID: 15152936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved pharmacological profile of the lipophilic antitumor dichloro-(N-dodecyl)-propanediamine-platinum(II) complex after incorporation into pegylated liposomes.
    Silva H; Silva AC; Lemos FO; Monte-Neto RL; Fontes AP; Lopes MT; Frézard F
    Anticancer Drugs; 2013 Feb; 24(2):131-9. PubMed ID: 23011234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome formulations for effective administration of lipophilic malonatoplatinum(II) complexes.
    Han I; Jun MS; Kim MK; Kim JC; Sohn YS
    Jpn J Cancer Res; 2002 Nov; 93(11):1244-9. PubMed ID: 12460466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.